Good morning :)
Switch to
Place Order

Astrazeneca Pharma India Ltd

ASTRAZEN
Health CarePharmaceuticals
SmallcapWith a market cap of ₹7,952 cr, stock is ranked 381
Low RiskStock is 1.98x as volatile as Nifty
3,180.85143.95 (+4.74%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Health CarePharmaceuticals
SmallcapWith a market cap of ₹7,952 cr, stock is ranked 381
Low RiskStock is 1.98x as volatile as Nifty

Key Metrics

PE RatioPE Ratio
85.23
PB RatioPB Ratio
17.43
Dividend YieldDiv. Yield
0.06%
Sector PESector PE
38.74
Sector PBSector PB
5.18
Sector Div YldSctr Div Yld
0.66%

Forecast & RatingsDetailed Forecast 

Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

AstraZeneca Pharma India Limited is a biopharmaceutical company engaged in the discovery, development and commercialization of medicines for core areas of healthcare.

Brands

Astrazeneca Pharma

Pharmaceutical company

Brands

Astrazeneca Pharma

Pharmaceutical company

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

Financial TrendFinancial statements 

2018201920202021583.25744.58844.80826.4025.9154.4572.2193.30
Revenue
Profit
All values in ₹ cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent EventsAll events 

Loss of Share Certificates 
Announced OnNov 17, 2021

AstraZeneca Pharma India Limited has informed the Exchange about Loss of Share Certificates | Download

AstraZeneca Pharma India Limited has informed the Exchange about Loss of Share Certificates | Download

Financial Result Updates 
Announced OnNov 9, 2021

AstraZeneca Pharma India Limited has submitted to the Exchange, the financial results for the period ended September 30, 2021. | Download

AstraZeneca Pharma India Limited has submitted to the Exchange, the financial results for the period ended September 30, 2021. | Download

Cash Dividend 
Ex. DateAug 18, 2021

Interim • Div/Share: ₹ 2

See all events